Children with multiple endocrine neoplasia type 2B: Not tall and marfanoid, but short with normal body proportions
暂无分享,去创建一个
[1] V. Wolters,et al. Timely diagnosis of multiple endocrine neoplasia 2B by identification of intestinal ganglioneuromatosis: a case series , 2021, Endocrine.
[2] P. Vorwerk,et al. Multiple endocrine neoplasia type 2B: Frequency of physical stigmata—Results of the GPOH‐MET registry , 2019, Pediatric blood & cancer.
[3] A. Tabarin,et al. Natural history, treatment, and long-term follow up of patients with multiple endocrine neoplasia type 2B: an international, multicentre, retrospective study. , 2019, The lancet. Diabetes & endocrinology.
[4] T. Ørntoft,et al. Incidence and prevalence of multiple endocrine neoplasia 2B in Denmark: a nationwide study. , 2017, Endocrine-related cancer.
[5] P. Morrison,et al. Epidemiology, clinical features, and genetics of multiple endocrine neoplasia type 2B in a complete population. , 2014, The oncologist.
[6] R. Menon,et al. Ectopic Cushing syndrome secondary to metastatic medullary thyroid cancer in a child with multiple endocrine neoplasia syndrome type 2B: clues to early diagnosis of the paraneoplastic syndromes , 2014, Journal of pediatric endocrinology & metabolism : JPEM.
[7] Stef van Buuren,et al. The world’s tallest nation has stopped growing taller: the height of Dutch children from 1955 to 2009 , 2013, Pediatric Research.
[8] Laurence Faivre,et al. The revised Ghent nosology for the Marfan syndrome , 2010, Journal of Medical Genetics.
[9] S. Hess,et al. Premonitory symptoms preceding metastatic medullary thyroid cancer in MEN 2B: An exploratory analysis. , 2008, Surgery.
[10] İ. Yolbaş,et al. Relationships between leptin, insulin, IGF-1 and IGFBP-3 in children with energy malnutrition. , 2007, Clinical biochemistry.
[11] A. Juul. Serum levels of insulin-like growth factor I and its binding proteins in health and disease. , 2003, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.
[12] C. Eng,et al. Intestinal ganglioneuromatosis and multiple endocrine neoplasia type 2B: implications for treatment , 1999, Gut.
[13] P. Morrison,et al. Multiple endocrine neoplasia type 2B (mucosal neuroma syndrome, Wagenmann-Froboese syndrome). , 1996, Journal of medical genetics.
[14] P. Goodfellow,et al. Single missense mutation in the tyrosine kinase catalytic domain of the RET protooncogene is associated with multiple endocrine neoplasia type 2B. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[15] C. Healey,et al. Point mutation within the tyrosine kinase domain of the RET proto-oncogene in multiple endocrine neoplasia type 2B and related sporadic tumours. , 1994, Human molecular genetics.
[16] R. Hofstra,et al. A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma , 1994, Nature.
[17] H. Vasen,et al. The natural course of multiple endocrine neoplasia type IIb. A study of 18 cases. , 1992, Archives of internal medicine.
[18] B. Jones,et al. Early diagnosis and thyroidectomy in multiple endocrine neoplasia, type 2b. , 1983, The Journal of pediatrics.
[19] J. Carney,et al. Multiple endocrine neoplasia with skeletal manifestations. , 1981, The Journal of bone and joint surgery. American volume.
[20] T. Aceto,et al. Multiple endocrine neoplasia, type 2B, with medullary thyroid carcinoma: a diagnostic potential for dentistry. , 1979, Pediatric dentistry.